Nativis, a Seattle-based company developing a device that uses low-frequency radio energy waves to treat cancer and other diseases, announced… Read More
Astellas Pharma, a Japanese pharmaceutical and biotechnology company, is acquiring Seattle biotech Universal Cells. Astellas will pay up to $102.5… Read More
Seattle’s Center for Infectious Disease Research announced Tuesday that it has received a new, $17.2 million grant from the National Institute… Read More
Seattle Children’s, the largest children’s hospital and pediatric research center in Washington state, says it has received the second largest… Read More
StayWell, a Pennsylvania-based subsidiary of pharmaceutical giant Merck, announced Monday that it has acquired Portland, Ore., based digital health company… Read More
Seattle biotech company PhaseRX is being bought by multinational drug commercialization company Roivant Sciences, according to an SEC filing. Roivant… Read More
Seattle Genetics, a Seattle-based biotechnology company that makes the cancer therapy Adcetris, beat Wall Street expectations in its 2017 earnings… Read More
Seattle Genetics, a biotechnology company that develops antibody-based cancer treatments, announced Wednesday that it will acquire Cascadian Therapeutics and the… Read More
Juno Therapeutics, the Seattle-based biotech company making cutting-edge cancer immunotherapy treatments, has reached a deal to be acquired by New Jersey-based… Read More
